Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-11-15 Purchase |
2021-11-16 4:25 pm |
Xeris Biopharma Holdings Inc. | XERS | Edick Paul R See Remarks |
20,000 | $2.2832 | $45,664 | 841,494 (Indirect Direct) |
View |
| 2021-11-11 Purchase |
2021-11-12 5:12 pm |
Xeris Biopharma Holdings Inc. | XERS | Shannon John Patrick Jr See Remarks |
100,000 | $2.095 | $209,500 | 363,829 (Direct) |
View |
| 2021-11-11 Purchase |
2021-11-12 5:09 pm |
Xeris Biopharma Holdings Inc. | XERS | Edick Paul R See Remarks |
200,000 | $2.0788 | $415,760 | 821,494 (Indirect Direct) |
View |
| 2021-11-10 Purchase |
2021-11-12 5:06 pm |
Xeris Biopharma Holdings Inc. | XERS | Pieper Steven See Remarks |
25,000 | $1.9967 | $49,918 | 183,108 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-01-03 Option Award |
2022-01-05 6:15 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
75,000 | $0 | 569,780 (Direct) |
View |
| 2021-10-05 Option Award(A) |
2021-10-08 6:30 pm |
N/A 2025-10-16 |
Xeris Biopharma Holdings Inc. | XERS | Kong Garheng Director |
171,207 | $0 | 190,857 (Direct) |
View |
| 2021-10-05 Option Award(A) |
2021-10-08 6:30 pm |
N/A 2031-10-05 |
Xeris Biopharma Holdings Inc. | XERS | Kong Garheng Director |
19,650 | $2.37 | 190,857 (Direct) |
View |
| 2021-10-05 Option Award(A) |
2021-10-08 6:29 pm |
N/A 2025-10-16 |
Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director |
866,959 | $0 | 886,609 (Direct) |
View |
| 2021-10-05 Option Award(A) |
2021-10-08 6:29 pm |
N/A 2031-10-05 |
Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director |
19,650 | $2.37 | 886,609 (Direct) |
View |
| 2021-10-05 Option Award |
2021-10-05 7:53 pm |
N/A 2025-10-16 |
Xeris Biopharma Holdings Inc. | XERS | Kong Garheng Director |
171,207 | $0 | 171,207 (Direct) |
View |
| 2021-10-05 Option Award |
2021-10-05 7:52 pm |
N/A 2025-10-16 |
Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director |
866,959 | $0 | 866,959 (Direct) |
View |
| 2021-10-05 Option Award |
2021-10-05 7:51 pm |
N/A 2028-05-15 |
Xeris Biopharma Holdings Inc. | XERS | HALKUFF DAWN Director |
62,106 | $0 | 62,106 (Direct) |
View |
| 2021-10-05 Option Award |
2021-10-05 7:50 pm |
N/A 2028-05-15 |
Xeris Biopharma Holdings Inc. | XERS | BORMANN-KENNEDY BARBARA-JEAN ANNE Director |
62,106 | $0 | 62,106 (Direct) |
View |
| 2021-10-05 Option Award |
2021-10-05 7:49 pm |
N/A 2027-01-27 |
Xeris Biopharma Holdings Inc. | XERS | Edick Paul R See Remarks |
2,057,633 | $0 | 2,057,633 (Direct) |
View |
| 2021-10-05 Option Award |
2021-10-05 7:47 pm |
N/A 2027-02-03 |
Xeris Biopharma Holdings Inc. | XERS | Shannon John Patrick Jr See Remarks |
692,349 | $0 | 692,349 (Direct) |
View |
| 2021-10-05 Option Award |
2021-10-05 7:46 pm |
N/A 2022-02-23 |
Xeris Biopharma Holdings Inc. | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
609,382 | $0 | 609,382 (Direct) |
View |
| 2021-10-05 Option Award |
2021-10-05 7:44 pm |
N/A 2028-05-15 |
Xeris Biopharma Holdings Inc. | XERS | PERSKY MARLA Director |
62,106 | $0 | 62,106 (Direct) |
View |
| 2021-10-05 Option Award |
2021-10-05 7:43 pm |
N/A 2027-02-04 |
Xeris Biopharma Holdings Inc. | XERS | Pieper Steven Chief Financial Officer |
232,018 | $0 | 232,018 (Direct) |
View |
| 2021-10-05 Option Award |
2021-10-05 7:41 pm |
N/A 2028-05-15 |
Xeris Biopharma Holdings Inc. | XERS | Schmid John P. Director |
73,335 | $0 | 73,335 (Direct) |
View |
| 2021-10-05 Option Award |
2021-10-05 7:41 pm |
N/A 2026-10-01 |
Xeris Biopharma Holdings Inc. | XERS | SHERMAN JEFFREY W Director |
222,244 | $0 | 222,244 (Direct) |
View |
| 2021-10-05 Option Award |
2021-10-05 7:38 pm |
N/A 2027-02-04 |
Xeris Biopharma Holdings Inc. | XERS | JOHNSON KENNETH ERLAND See Remarks |
322,083 | $0 | 322,083 (Direct) |
View |
| 2021-10-05 Option Award |
2021-10-05 7:37 pm |
N/A 2028-01-30 |
Xeris Biopharma Holdings Inc. | XERS | Hecht Beth See Remarks |
488,866 | $0 | 488,866 (Direct) |
View |